Fresenius Kabi
Jens Strohmenger possesses extensive experience in process digitalization, analytics, and strategic sourcing, currently serving as Vice President of Process Digitalization & Analytics at Fresenius Kabi since April 2007. Notable roles include Vice President of Advanced Manufacturing Analytics & Performance Projects and Global Business Process Owner for Business Intelligence, Reporting & Planning. Jens has a strong foundation in controlling and global sourcing processes, previously holding the position of Senior Controller at AB Enzymes and Junior Production Controller at Ciba. Jens's academic background includes degrees in international business relationship & administration and chemical process engineering from Fachhochschule Nuertingen and Fachhochschule Darmstadt, respectively.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.